| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,220 |
2,515 |
$194K |
| 76830 |
Ultrasound, transvaginal |
1,989 |
1,901 |
$178K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
808 |
776 |
$111K |
| 87800 |
|
2,387 |
2,334 |
$85K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,864 |
2,766 |
$80K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,864 |
2,766 |
$80K |
| 87806 |
|
1,475 |
1,419 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
594 |
581 |
$33K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
737 |
653 |
$29K |
| 86703 |
|
2,312 |
2,280 |
$27K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
412 |
353 |
$26K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
291 |
285 |
$25K |
| 99000 |
|
2,247 |
2,094 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,692 |
1,665 |
$23K |
| 86762 |
|
1,859 |
1,824 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,365 |
3,271 |
$21K |
| 81025 |
|
2,562 |
2,498 |
$18K |
| 80061 |
Lipid panel |
2,503 |
2,450 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,091 |
2,033 |
$17K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
262 |
238 |
$14K |
| 86787 |
|
1,372 |
1,328 |
$13K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
233 |
221 |
$13K |
| 84144 |
|
767 |
517 |
$12K |
| H1010 |
Non-medical family planning education, per session |
1,013 |
1,004 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
823 |
790 |
$11K |
| 86592 |
|
2,909 |
2,843 |
$10K |
| 84702 |
|
777 |
522 |
$10K |
| 82947 |
|
2,732 |
2,651 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
110 |
109 |
$8K |
| 76813 |
|
80 |
77 |
$7K |
| 81003 |
|
3,334 |
3,191 |
$6K |
| 86580 |
|
754 |
722 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
356 |
312 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
385 |
371 |
$5K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
71 |
69 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
42 |
42 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
34 |
34 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
324 |
186 |
$3K |
| 83655 |
|
256 |
251 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 82950 |
|
235 |
227 |
$877.80 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
20 |
$777.84 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
52 |
26 |
$722.80 |
| 87481 |
|
94 |
46 |
$678.04 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
16 |
$662.08 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
47 |
46 |
$432.68 |
| 90715 |
|
13 |
13 |
$415.42 |
| 90461 |
|
52 |
44 |
$390.23 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
40 |
30 |
$364.80 |
| 87420 |
|
26 |
26 |
$303.68 |
| 86696 |
|
12 |
12 |
$267.60 |
| 90658 |
|
120 |
119 |
$0.48 |
| 90680 |
|
12 |
12 |
$0.00 |
| 90670 |
|
31 |
31 |
$0.00 |